KWF
CDD Scouting Programme
Rolling deadline
Last seen in a scan/import: .
Catalog updated: .
These timestamps are not source verification. Confirm the current deadline and your eligibility on the funder’s call page before applying.
No deadline is on file for this call. Check KWF's own call page for the current round's status before you plan around it.
The CDD Scouting Programme funds late-stage preclinical to early clinical (Phase I/IIa) oncology drug candidates developed by Dutch academic groups and biotech companies, with KWF contributing up to €2 million per project alongside co-funding from Cancer Research UK's Centre for Drug Development. The call runs year-round on a rolling basis and requires applicants to hold or secure full intellectual property rights and freedom to operate. This is a multi-stage process emphasising clinical translation and international development partnerships.
Details
| Funder | KWF |
| Budget | Up to €2M per project |
| Consortium | Required - project team and Cancer Research UK Centre for Drug Development/Cancer Research Horizons via project-specific agreement |
| Application | Scouting form -> internal KWF assessment -> CDD introductory call -> Stage 1 review -> NDA -> Stage 2+ reviews -> funding decision |
| TRL | 6-8 |
| Frequency | Continuous |
| Eligible countries | NL |
Eligibility & scope
For Dutch academic groups and (spin-off) companies developing novel oncology drug candidates in late-stage preclinical development or approaching first-in-human studies, co-funded with Cancer Research UK's Centre for Drug Development. Applicants must hold or be able to secure IP rights and freedom to operate; non-Dutch initiators and repurposing of registered drugs are out of scope.
Who Should Apply
- •Dutch academic research groups with late-stage preclinical or early clinical oncology candidates
- •Dutch biotech and spin-off companies developing novel or repurposed non-registered pharmaceuticals
- •Applicants holding or able to secure complete IP rights and freedom to operate
- •Projects with strong clinical development partners or willingness to engage international collaborators
Key Dates
- •Rolling applications year-round; scouting form submitted to KWF initiates multi-stage review
- •Multi-stage process: scouting form, KWF assessment, CDD review, Stage 1 and Stage 2 review gates
- •Timeline from application to KWF funding decision varies with stage progression
Tips for Applicants
- ✓Include a named clinical trial partner or signal early willingness to engage one; KWF strongly prefers Dutch centres in trial consortia.
- ✓Prepare IP documentation early, applicants must demonstrate full rights or a credible path to securing them before NDA phase.
- ✓The scouting form is not perfunctory; clarity on drug class, target, and clinical-readiness stage determines which review track you enter.
Frequently Asked Questions
What stage of drug development does the CDD Scouting Programme fund?
Late-stage preclinical to early clinical (Phase I/IIa) oncology candidates, covering technology readiness levels 6-8.
How much does the CDD Scouting Programme pay?
KWF contributes up to €2 million per project; total budgets are typically supplemented by co-funding from Cancer Research UK's Centre for Drug Development.
Who can apply to the CDD Scouting Programme?
Dutch academic research groups and biotech or spin-off companies based in the Netherlands working on novel oncology therapeutics with secured or securable IP rights and freedom to operate.
Is the CDD Scouting Programme a one-time submission or rolling?
The programme runs year-round with rolling applications; you submit a scouting form to KWF at any time to initiate the multi-stage review process.
Related on Grantsby
- KWF writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
Similar grants
Drug Development Project
Cancer Research UKChildhood Cancer Therapeutic Catalyst
Cancer Research UKUp to £250kTherapeutic Catalyst - Early Therapy Award
Cancer Research UKDeadline: 5 Feb 2027Up to £350KNext steps
CancerfondenDeadline: 15 Dec 2026Therapeutic Catalyst - Target Award
Cancer Research UKDeadline: 5 Feb 2027Up to £250K
Browse Related
Could CDD Scouting Programme be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →